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Abstract
A 60 year-old woman with rheumatic mitral stenosis underwent re-replacement of Cross-
-Jones caged lens mitral valve prosthesis, 36 years after valve implantation. In 1968, she
underwent mitral commissurotomy. In 1992, she had a stroke, and in July 2009 echocardiography
revealed the malfunction of the prosthesis with pannus and reduced mitral prosthetic area
< 1.0 cm2 with the elevated transprosthetic gradient of 30 mm Hg. To begin with, she did not
approve of the reoperation. Finally, she consented to this therapeutic option. In October 2009
Medtronic prosthesis Advantage 27 was re-implanted. We report the longest period of working
Cross-Jones mitral valve in the literature. (Cardiol J 2011; 18, 6: 698–700)
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Introduction
The Cross-Jones prosthesis was implanted by
Cross, its constructor, early in 1965 for the first
time. It heralded an era of low profile prostheses
implanted in the mitral position, something prefer-
able in patients with narrow left ventricle output [1].
In the 1970s, following reports of fatal malfunctions
of this type of prosthesis, an elective replacement
was recommended in patients who still had their
functioning artificial valve [1].
Case report
We report a 60 year-old woman with rheuma-
tic mitral stenosis, who underwent re-replacement
of mitral valve prosthesis 36 years after valve im-
plantation. She had a Cross-Jones caged-lens pros-
thesis implanted in 1973. In 1968, she underwent the
first valve operation, mitral commissurotomy. After
that, she became pregnant and delivered a healthy
boy. In 1979 and 1980, fatal malfunctions of Cross-
-Jones caged-lens prostheses were reported [2, 3],
but the patient in question was well and nobody
proposed she should be re-operated. She used an
anticoagulant drug (acenokumarol) with not well
controlling International Normalized Ratio (INR).
She had a long-term history of atrial fibrillation,
arterial hypertension and smoking.
In 1992, she had a stroke with left-sided pare-
sis and senso-motoric aphasia. It is unknown if
echocardiography was performed after this incident.
Between 2006 and 2008 she was hospitalized four
times for pulmonary oedema. Until 2009 she had
been under the care of her General Practitioner.
In 2009, she was admitted to hospital twice: for the
first time in July with signs of bad care of anticoag-
ulation status (INR > 10), haematuria and bleeding
from peptic ulcer. She obtained 4 U of red cells and
omeprazol i.v. Gastroscopy confirmed a peptic
ulcer in the duodenum. Echocardiography revealed
malfunction of the prosthesis with pannus and mi-
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tral prosthetic area < 1.0 cm2. The pannus forma-
tion occurred on the atrial and ventricle side of the
prosthesis. The transvalvular leak was periodically
recorded. The left atrium was enlarged (7 × 5.8 cm).
Left and right ventricular function was impeded
(EF = 60%, TAM 24 mm). Systolic pulmonary pres-
sure was elevated to about 44 mm Hg and mild tri-
cuspid regurgitation was observed. In this time she
was referred for re-operation but she refused.
Two months later, she was admitted with signs
of decompensation in NYHA class IV. A tran-
soesophageal echocardiogram recorded a further
malfunction of the prosthesis (Fig. 1) with the ele-
vated transprosthetic gradient of 30 mm Hg, its
abnormal movement and periodical out of the trans-
valvular flow. Additionally mobile thrombi 10–12 mm
occured on the atrial side of the prosthesis. Final-
ly, she consented to a surgical operation. Moreo-
ver, she underwent the extraction of teeth using an-
tibiotic prophylaxis for infective endocarditis and
coronary arteriography without narrowing of coro-
nary arteries.
In October 2009, she underwent cardiopulmo-
nary bypass surgery. Cardiac arrest was achieved
with antegrade crystalloid cold cardioplegia. From
the atrial side, the Cross-Jones prosthesis was near-
ly totally obscured by the pannus formation and
thrombi (Fig. 2A). After removal of the prosthesis,
it was revealed that thrombi from the ventricular
side restricted the movement of the disc in the pros-
thetic cage (Fig. 2B). Furthermore, the silicone disc
had an irregular rim and was damaged (Fig. 2C). The
pannus was maximally excised and the Medtronic
prosthesis Advantage 27 was implanted. We used
2–0 interrupted pledgetted sutures, which were
introduced from the atrial side towards the ventri-
cle in an inverted ‘U’ fashion. The early post-oper-
ative period was without complication. She left hos-
pital on the 21st day after her operation without any
signs of decompensation.
Discussion
We describe the 36 years of working of a mi-
tral Cross-Jones caged disc prosthesis implanted in
the mitral position in 1973. The Cross-Jones pros-
thesis was one of the first with a low profile cage.
The silicone disc was elastic, as all silicone details
were. This was the cause of many malfunctions of
implanted prostheses, so this type of valve was re-
placed by new one-tilting disc valves. In 1967, the
Björk-Shiley valve started the era of tilting disc
prostheses [1]. As we know, the history of cardiac
valve prostheses began in 1952 with Hufnagel
Figure 2. View of thrombotic encapsulation of Cross-Jones prosthesis in mitral position: A. From the atrial side;
B. From the ventricular side; C. The damaged disc with irregular rim.
Figure 1. Preoperative transoesophageal echocardio-
gram with thrombus on the Cross-Jones prosthesis in
mitral position and irregular transvalvular flow; LA —
left atrial; LV — left ventricle.
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[4, 5]. Still today, there are many working mecha-
nisms. More than 70 were patented in the US, but
less than ten types were actually implanted in the
US and Europe [5].
To the best of our knowledge, there are few
reports in the literature about the Cross-Jones mi-
tral valve prosthesis. An early fatal malfunction of
a Cross-Jones mitral valve prosthesis, 20 months
after surgery where the disc escaped into the left
atrium, was described by Lucács and Lónyai in 1980
[2]. A fatal retrograde dislodgement of a Cross-
-Jones valve lenticular disc seven years after sur-
gery was observed by Schachner et al. in 1979 [3].
A late outcome 23 years after surgery of a Cross-
Jones in the mitral position was published by Gosh
et al. [6]. The largest study of Cross-Jones prosthe-
ses was reported by Kovacs et al. [7], with 121 pa-
tients and 145 implanted valves between 1967 and
1973 in Hungary, followed-up for more than
20 years. They observed no mechanical failures of the
valve in the aortic position 24 years after surgery.
In seven patients, the disc escaped from the mitral
position, causing death. In mitral patients, the over-
all incidence of thromboembolism was 23.4%/pa-
tient per year.
We do not know either how long is the history
of malfunction of the prosthesis in our patient (from
the first pulmonary oedema?) or if it was depend-
ent solely on the construction and material of the
valve, or also on poorly controlled anticoagulation
therapy. It seems that both the above described
mechanisms were in this case important.
In summary, we report the longest period of
a working Cross-Jones mitral valve, not only in our
department but also in the literature.
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